Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||
| Income Statement [Abstract] | ||||||
| Revenue | $ 1,163 | $ 976 | $ 1,991 | $ 1,977 | ||
| Operating expenses: | ||||||
| Cost of revenue | 1,563 | 1,614 | 3,114 | 3,269 | ||
| Sales and marketing | 4,007 | 4,210 | 8,076 | 8,404 | ||
| General and administrative | 5,617 | 4,867 | 11,779 | 8,937 | ||
| Amortization of acquired intangible assets | 105 | 105 | 210 | 477 | ||
| Research and development | 1,255 | 1,372 | 2,683 | 2,873 | ||
| Total operating expenses | 12,547 | 12,168 | 25,862 | 23,960 | ||
| Operating loss | (11,384) | (11,192) | (23,871) | (21,983) | ||
| Other income (expense): | ||||||
| Interest income | 110 | 107 | 176 | 175 | ||
| Interest expense | (6) | (6) | (14) | (18) | ||
| Change in fair value - Senior Secured Convertible Note | 6,841 | 599 | (7,638) | 890 | ||
| Debt extinguishments loss - Senior Secured Convertible Note | (513) | (681) | ||||
| Other income (expense), net | 6,945 | 187 | (7,476) | 366 | ||
| Loss before provision for income tax | (4,439) | (11,005) | (31,347) | (21,617) | ||
| Provision for income taxes | ||||||
| Net loss attributable to Lucid Diagnostics Inc. | (4,439) | (11,005) | (31,347) | (21,617) | ||
| Less: Deemed dividend on Series A and Series A-1 Convertible Preferred Stock | (7,496) | |||||
| Less: Series B and Series B-1 Convertible Preferred Stock dividends earned | (3,449) | (12,559) | ||||
| Net loss attributable to Lucid Diagnostics Inc. common stockholders | $ (7,888) | $ (11,005) | $ (43,906) | $ (29,113) | ||
| Net loss per share attributable to Lucid Diagnostics Inc. common stockholders - basic | [1] | $ (0.08) | $ (0.23) | $ (0.52) | $ (0.62) | |
| Net loss per share attributable to Lucid Diagnostics Inc. common stockholders - diluted | [1] | $ (0.08) | $ (0.23) | $ (0.52) | $ (0.62) | |
| Weighted average common shares outstanding, basic | 98,989,161 | 48,212,040 | 83,976,182 | 46,613,362 | ||
| Weighted average common shares outstanding, diluted | 98,989,161 | 48,212,040 | 83,976,182 | 46,613,362 | ||
| ||||||
| X | ||||||||||
- Definition Change in fair value senior secured convertible note. No definition available.
|
| X | ||||||||||
- Definition Operating cost of revenue. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|